Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children

被引:11
|
作者
Gomez, Lauren A. [1 ]
Crowell, Claudia S. [2 ,3 ]
Njuguna, Irene [4 ]
Cranmer, Lisa M. [5 ,6 ]
Wamalwa, Dalton [4 ]
Chebet, Daisy [4 ]
Otieno, Vincent [4 ]
Maleche-Obimbo, Elizabeth [4 ]
Gladstone, Melissa [7 ]
John-Stewart, Grace [1 ]
Benki-Nugent, Sarah [1 ]
机构
[1] Univ Washington, Dept Global Hlth, Box 359909,325 9th Ave, Seattle, WA 98104 USA
[2] Univ Washington, Dept Pediat, Div Pediat Infect Dis, Seattle, WA 98195 USA
[3] Seattle Childrens Hosp, Seattle, WA USA
[4] Univ Nairobi, Dept Paediat & Child Hlth, Nairobi, Kenya
[5] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA
[6] Childrens Healthcare Atlanta, Atlanta, GA USA
[7] Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England
基金
美国国家卫生研究院;
关键词
child development; nutrition; Africa; Malawi Developmental Assessment Tool; PERINATALLY ACQUIRED HIV; MOTOR DEVELOPMENT; UGANDAN CHILDREN; DISEASE SEVERITY; SOUTH-AFRICA; OUTCOMES; INFANTS; ADOLESCENTS; MORTALITY; PROGRAM;
D O I
10.1097/INF.0000000000001942
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Late human immunodeficiency virus (HIV) diagnosis after severe co-morbidity remains common in resource-limited settings. Neurodevelopmental recovery during antiretroviral therapy (ART) for late-diagnosed children is understudied. We determined 6-month neurodevelopmental trajectories in HIV-infected children initiating ART during hospitalization. Methods: HIV-infected children initiated ART after HIV diagnosis during hospitalization in Kenya. The Malawi Developmental Assessment Tool was administered after clinical stabilization within 1 month and at 6 months post-ART initiation. Baseline versus 6-month Z scores for each developmental domain were compared; cofactors for change in Z scores were evaluated using linear regression. Results: Among 74 children, median age was 1.7 years (interquartile range, 0.8-2.4) and median Z scores for gross motor, fine motor, social and language domains were -1.34, -1.04, -0.53 and -0.95, respectively. At baseline, children with higher plasma viremia had lower social Z scores (P = 0.008). Better nourished (weight-for-age Z score [WAZ] -2) children had higher Z scores in all developmental domains (all P values 0.05). After 6 months on ART (n = 58), gross and fine motor Z scores improved significantly (mean change 0.39; P = 0.007 and 0.43; P = 0.001, respectively), but social and language did not. Children with better immune and growth response to ART had higher gains in gross motor (0.05 per unit-gain CD4%; P = 0.04; 0.34 per unit-gain WAZ; P = 0.006 and 0.44 per unit-gain height-for-age Z score; P = 0.005), social (0.37 per unit-gain WAZ; P = 0.002) and language (0.25 per unit-gain height-for-age Z score; P = 0.01). Conclusions: Children had significant neurodevelopmental gains during 6 months of ART, and children with better growth and immune recovery had greater improvement. Prompt commencement of ART may improve neurodevelopment in addition to immunity and growth.
引用
收藏
页码:916 / 922
页数:7
相关论文
共 50 条
  • [41] Effects of the change from stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy
    Rosso, Raffaella
    Nasi, Milena
    Di Biagio, Antonio
    Repetto, Ernestina
    Dentone, Chiara
    Pinti, Marcello
    Nemes, Elisa
    Ferraresi, Roberta
    Mussini, Cristina
    Esposito, Roberto
    Viscoli, Claudio
    Cossarizza, Andrea
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (01) : 17 - 21
  • [42] Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy
    Esposito, S
    Bojanin, J
    Porta, A
    Cesati, L
    Gualtieri, L
    Principi, N
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (12) : 1117 - 1120
  • [43] Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children
    Muenchhoff, Maximilian
    Adland, Emily
    Roider, Julia
    Kloverpris, Henrik
    Leslie, Alasdair
    Boehm, Stephan
    Keppler, Oliver T.
    Ndung'u, Thumbi
    Goulder, Philip J. R.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (09): : 1407 - 1417
  • [44] The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children
    Mellins, CA
    Brackis-Cott, E
    Dolezal, C
    Abrams, EJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (11) : 1035 - 1041
  • [45] PHARMACOKINETICS OF DAPSONE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN
    GATTI, G
    LOY, A
    CASAZZA, R
    MILETICH, F
    CRUCIANI, M
    BASSETTI, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) : 1101 - 1106
  • [46] Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children
    Berkelhamer, S
    Borock, E
    Elsen, C
    Englund, J
    Johnson, D
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (07) : 1090 - 1094
  • [47] Salvage lopinavir-ritonavir therapy in human immunodeficiency virus-infected children
    Resino, S
    Bellón, JM
    Ramos, JT
    Navarro, ML
    Martín-Fontelos, P
    Cabrero, E
    Muñoz-Fernández, MA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (10) : 923 - 930
  • [48] Lipodystrophy syndrome in human immunodeficiency virus-infected children
    Amaya, RA
    Kozinetz, CA
    McMeans, A
    Schwarzwald, H
    Kline, MW
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (05) : 405 - 410
  • [49] Campylobacter sepsis in human immunodeficiency virus-infected children
    RuizContreras, J
    Ramos, JT
    HernandezSampelayo, T
    deJose, M
    Clemente, J
    Gurbindo, MD
    Bravo, J
    Cilleruelo, MJ
    deMiguel, MJG
    MartinFontelos, P
    Mellado, MJ
    Saavedra, J
    Villolta, J
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (02) : 251 - 253
  • [50] Adenovirus viremia in human immunodeficiency virus-infected children
    Ferdman, RM
    Ross, L
    Inderlied, C
    Church, JA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (04) : 413 - 415